123 related articles for article (PubMed ID: 16524971)
1. EGFR in colorectal cancer: more than a simple receptor.
Francoual M; Etienne-Grimaldi MC; Formento JL; Benchimol D; Bourgeon A; Chazal M; Letoublon C; André T; Gilly N; Delpero JR; Lasser P; Spano JP; Milano G
Ann Oncol; 2006 Jun; 17(6):962-7. PubMed ID: 16524971
[TBL] [Abstract][Full Text] [Related]
2. EGF receptor and COX-1/COX-2 enzyme proteins as related to corresponding mRNAs in human per-operative biopsies of colorectal cancer.
Asting AG; Farivar A; Iresjö BM; Svensson H; Gustavsson B; Lundholm K
BMC Cancer; 2013 Oct; 13():511. PubMed ID: 24171795
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor levels are lower in carcinomatous than in normal colorectal tissue.
Koenders PG; Peters WH; Wobbes T; Beex LV; Nagengast FM; Benraad TJ
Br J Cancer; 1992 Feb; 65(2):189-92. PubMed ID: 1739615
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of erbB3 in colorectal cancer is associated with concomitant increase in the level of erbB2.
Maurer CA; Friess H; Kretschmann B; Zimmermann A; Stauffer A; Baer HU; Korc M; Büchler MW
Hum Pathol; 1998 Aug; 29(8):771-7. PubMed ID: 9712416
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor (EGFR) status in primary colorectal tumors correlates with EGFR expression in related metastatic sites: biological and clinical implications.
Italiano A; Saint-Paul MC; Caroli-Bosc FX; François E; Bourgeon A; Benchimol D; Gugenheim J; Michiels JF
Ann Oncol; 2005 Sep; 16(9):1503-7. PubMed ID: 15980160
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin binding in normal and malignant human gastrointestinal mucosa.
Miller GV; Farmery SM; Woodhouse LF; Primrose JN
Br J Cancer; 1992 Aug; 66(2):391-5. PubMed ID: 1354473
[TBL] [Abstract][Full Text] [Related]
7. Expression of epidermal growth factor receptor in normal colorectal mucosa, adenoma, and carcinoma.
Koretz K; Schlag P; Möller P
Virchows Arch A Pathol Anat Histopathol; 1990; 416(4):343-9. PubMed ID: 2106751
[TBL] [Abstract][Full Text] [Related]
8. Discordance between EGFR expression and clinicopathologic parameters of colorectal adenocarcinoma in Taiwan.
Tsai WC; Lin CK; Lee HS; Chen A; Nieh S; Yu CP; Wu CC; Jao SW; Jin JS
Chin J Physiol; 2012 Oct; 55(5):352-60. PubMed ID: 23282210
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment with EGFR-targeted monoclonal antibodies.
Scartozzi M; Bearzi I; Berardi R; Mandolesi A; Fabris G; Cascinu S
J Clin Oncol; 2004 Dec; 22(23):4772-8. PubMed ID: 15570078
[TBL] [Abstract][Full Text] [Related]
10. Receptors for epidermal growth factor and steroid hormones in primary colorectal tumors.
Scambia G; Panici PB; Bellantone R; Doglietto GB; Sofo L; Ferrandina G; Ratto C; Bossola M; Crucitti F; Spagnolo LC
J Surg Oncol; 1991 Nov; 48(3):183-7. PubMed ID: 1943115
[TBL] [Abstract][Full Text] [Related]
11. Signal transduction pathways of the epidermal growth factor receptor in colorectal cancer and their inhibition by small molecules.
Efferth T
Curr Med Chem; 2012; 19(33):5735-44. PubMed ID: 23033949
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor, c-MET, beta-catenin, and p53 expression as prognostic indicators in stage II colon cancer: a tissue microarray study.
Resnick MB; Routhier J; Konkin T; Sabo E; Pricolo VE
Clin Cancer Res; 2004 May; 10(9):3069-75. PubMed ID: 15131045
[TBL] [Abstract][Full Text] [Related]
13. [Immunohistochemical study on the expression of epidermal growth factor receptor (EGFR) in human colorectal carcinomas].
Takemura K; Obara T; Okano S; Yokota K; Ura H; Saitoh Y; Koike Y; Okamura K; Namiki M
Nihon Shokakibyo Gakkai Zasshi; 1991 May; 88(5):1177-83. PubMed ID: 1880949
[TBL] [Abstract][Full Text] [Related]
14. Expression of epidermal growth factor receptor (EGFR) in colorectal cancer: An immunohistochemical study.
Ben Brahim E; Ayari I; Jouini R; Atafi S; Koubaa W; Elloumi H; Chadli A
Arab J Gastroenterol; 2018 Sep; 19(3):121-124. PubMed ID: 30243897
[TBL] [Abstract][Full Text] [Related]
15. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the insulin-like growth factor I receptor in human colon carcinomas.
Weber MM; Fottner C; Liu SB; Jung MC; Engelhardt D; Baretton GB
Cancer; 2002 Nov; 95(10):2086-95. PubMed ID: 12412161
[TBL] [Abstract][Full Text] [Related]
17. EGFR, HER-2 and COX-2 levels in colorectal cancer.
Antonacopoulou AG; Tsamandas AC; Petsas T; Liava A; Scopa CD; Papavassiliou AG; Kalofonos HP
Histopathology; 2008 Dec; 53(6):698-706. PubMed ID: 19102009
[TBL] [Abstract][Full Text] [Related]
18. Expression of membranous epidermal growth factor receptor in colorectal adenocarcinoma and its correlation with clinicopathological features.
Mohammadi G; Jamialahmadi K; Lary S; Ghaffarzadegan K
Pak J Biol Sci; 2011 Mar; 14(5):357-62. PubMed ID: 21874828
[TBL] [Abstract][Full Text] [Related]
19. Predictive and prognostic factors in the complex treatment of patients with colorectal cancer.
László L
Magy Onkol; 2010 Dec; 54(4):383-94. PubMed ID: 21163770
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic significance of EGFR and Her-2/neu in colorectal adenocarcinomas.
Kountourakis P; Pavlakis K; Psyrri A; Rontogianni D; Xiros N; Patsouris E; Pectasides D; Economopoulos T
Cancer J; 2006; 12(3):229-36. PubMed ID: 16803682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
